Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:22:50.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition, with updates and FAQs available.
    Difference
    1%
    Check dated 2026-10-26T16:45:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T16:46:02.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T17:18:11.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with an access-restriction notice and standard site chrome.
    Difference
    0.5%
    Check dated 2026-09-28T19:18:35.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with basic navigation, indicating access is blocked. The previously visible study content and related sections such as CSR Synopsis, AstraZeneca details, and IPD sharing information were removed.
    Difference
    15%
    Check dated 2026-09-21T22:43:55.000Z thumbnail image

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.